Gyeonggi-do, South Korea

Soo-Youl Kim



Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Soo-Youl Kim: Pioneering Anti-Cancer Innovations

Introduction: Soo-Youl Kim, located in Gyeonggi-do, South Korea, is an accomplished inventor recognized for his significant contributions to the field of pharmaceuticals. With a keen focus on developing innovative compounds, Kim has made strides in cancer treatment through his groundbreaking research.

Latest Patents: Kim holds a patent for a unique compound titled "4-(aryl)-N-(3-alkoxyfuro[2,3-b]pyrazin-2-yl)-piperazine-1-carboxamide derivative." This invention focuses on a derivative compound that is useful in the prevention or treatment of cancer. The compound demonstrates an ability to effectively inhibit the growth of proliferating cells, highlighting its potential in providing therapeutic solutions for cancer patients.

Career Highlights: Currently, Soo-Youl Kim is affiliated with LSK NRDO Co., Ltd., where he continues to advance his research in oncology and pharmaceutical innovations. His dedication to inventing effective medical treatments showcases his commitment to improving health outcomes.

Collaborations: Throughout his career, Kim has worked alongside talented colleagues, including Young-Dae Gong and Eun Sil Lee. These collaborations contribute to a dynamic research environment, fostering the exchange of ideas that further propel innovative solutions in medicine.

Conclusion: Soo-Youl Kim stands out as a noteworthy inventor in the realm of cancer treatment innovations. His unique patent and collaborative efforts highlight his commitment to advancing healthcare. As the field of oncology continues to evolve, Kim's contributions are poised to play a crucial role in developing effective therapeutic options for cancer patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…